eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cardiogenic shock |
| Comorbidity | |myocardial infarct |
| Sentences | 147 |
| PubMedID- 25885579 | The data on the use of iabp in patients post myocardial infarction with cardiogenic shock remains inconclusive. |
| PubMedID- 24342343 | Support or not to support the left ventricle in patients with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 25536812 | Conclusion: the prompt diagnosis, especially in such relatively atypical clinical presentation, reperfusion therapy with primary percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock, contribute to the improvement in the survival rate and patient's quality of life. |
| PubMedID- 22437987 | We report the first case in which the impella 5.0 device was placed directly into the ascending aorta via a small right anterior thoracotomy in a patient following acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 22864324 | [acute anterior myocardial infarction presented with cardiogenic shock in a patient on herbal medication]. |
| PubMedID- 25983563 | The us impella registry reported the contrasting strategies of pre- and post-pci impella 2.5 placement in acute myocardial infarction patients complicated by cardiogenic shock.11 early circulatory support (pre-pci) improved hospital survival (65.1% vs 40.7%; p = 0.003) and remained an independent predictor after adjustment for confounding variables (odds ratio: 0.37; p = 0.01). |
| PubMedID- 19789449 | Objective: to evaluate the clinical and prognostic relevance of acute kidney injury (aki) in the setting of st-elevation acute myocardial infarction (stemi) complicated by cardiogenic shock (cs). |
| PubMedID- 26054832 | Device therapy: where next in cardiogenic shock owing to myocardial infarction. |
| PubMedID- 22739496 | Objectives: acute st elevation myocardial infarction (stemi) presenting with cardiogenic shock (cs) is associated with dismal prognosis. |
| PubMedID- 23918078 | Sixty-six months later, he had an acute myocardial infarction with cardiogenic shock due to simultaneous 3-vessel very late stent thrombosis (vlst). |
| PubMedID- 24133507 | Though there were three (8.8%) in-hospital deaths in our patients, none were procedure-related and all were caused by underlying extensive myocardial infarction with cardiogenic shock. |
| PubMedID- 24748798 | This case is an example of a patient who had an in-hospital cardiac arrest due to acute myocardial infarction, complicated by cardiogenic shock. |
| PubMedID- 20686421 | Objective: to assess the predictive value of three biomarkers for mortality in st-segment elevation myocardial infarction (stemi) with cardiogenic shock. |
| PubMedID- 21779281 | St elevation myocardial infarction with cardiogenic shock was more prevalent in the non-survivors than in the survivors (75% vs. 27.3%, p=0.04). |
| PubMedID- 21385075 | He died of a sudden myocardial infarction with cardiogenic shock 28 months after starting the combination of tkis. |
| PubMedID- 22013292 | [13] the various indications are acute myocardial infarction (mi) with cardiogenic shock, post-coronary artery bypass graft (high-risk cases with low ejection fraction of <20%), acute mitral insufficiency, and cardiac transplantation. |
| PubMedID- 21881355 | Objective: acute myocardial infarction (ami) complicated by cardiogenic shock and left main coronary artery disease (left main shock syndrome) shows high morbidity, and whether early coronary artery bypass grafting (cabg) improves the clinical outcome remains unclear. |
| PubMedID- 22431494 | Patients in a variety of cardiovascular disease states may benefit from temporary percutaneous cardiac support, including those in acute decompensated heart failure, fulminant myocarditis, acute myocardial infarction with or without cardiogenic shock and those undergoing high-risk percutaneous coronary intervention. |
| PubMedID- 22847042 | Efficacy and timing of intra-aortic counterpulsation in patients with st-elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 20690098 | Intra-aortic balloon pumps (iabp) are commonly used in the setting of an acute myocardial infarction that is complicated by cardiogenic shock or mechanical complications such as a ventricular septal defect or papillary muscle rupture. |
| PubMedID- 24492986 | We report the results of four patients with st elevation myocardial infarction, complicated by cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation treated with early levosimendan infusion during primary percutaneous coronary intervention. |
| PubMedID- 24903195 | Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the iabp-shock ii-trial. |
| PubMedID- 24848410 | Recent findings: recently published randomized controlled trials (rcts) and meta-analyses have demonstrated acceptable safety for iabp but have raised doubt over efficacy in acute myocardial infarction (mi) both with and without cardiogenic shock. |
| PubMedID- 24090250 | Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain st segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23179136 | Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the alkk-pci registry. |
| PubMedID- 23995129 | Furthermore, a large scale randomized trial found no benefit on 30-day mortality in patients with myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 23233759 | Six months post implant he experienced acute inferolateral st-segment elevation myocardial infarction complicated by cardiogenic shock and underwent successful primary percutaneous revascularization. |
| PubMedID- 24228641 | Objectives: to assess the relation between initial ecg findings, presence of risk factors, coronary angiography findings, and clinical outcomes in patients with acute myocardial infarction complicated by cardiogenic shock (cs). |
| PubMedID- 19108906 | We report a case of emergent percutaneous intervention to a cabrol graft-left main anastomosis in a patient who presented with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 26333723 | Angiopoietin-2 in acute myocardial infarction complicated by cardiogenic shock-a biomarker substudy of the iabp-shock ii-trial. |
| PubMedID- 21602670 | Methods: from january 2004 through august 2010, a total of 34 st-elevation myocardial infarction patients with profound cardiogenic shock were admitted to our intensive care unit and treated with either the impella 2.5 or the impella 5.0 device. |
| PubMedID- 24329756 | The current use of impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the uspella registry. |
| PubMedID- 22709745 | Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |
| PubMedID- 20662231 | We experienced a case of acute myocardial infarction (ami) with cardiogenic shock due to compression of the left main trunk (lmt) by a false lumen of an aad. |
| PubMedID- 22299378 | We present a case of acute myocardial infarction complicated with cardiogenic shock that underwent primary percutaneous coronary intervention and also review the incidence, pathophysiology, management and outcome of cardiogenic shock complicating acute myocardial infarction. |
| PubMedID- 20515862 | A 60-year-old man was admitted to our department with non st-segment elevation myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 24077607 | Recent findings: there have been decades of nonrandomized and observational data available, but only in the last 3 years has there been availability of randomized evidence for iabp use in acute myocardial infarction (ami) with cardiogenic shock, st elevation acute coronary syndromes (ste-acs) without shock and high-risk percutaneous coronary intervention (pci) cohorts. |
| PubMedID- 25822657 | Importance: intra-aortic balloon pump (iabp) therapy is a widely used intervention for acute myocardial infarction with cardiogenic shock. |
| PubMedID- 22767014 | The successful combined use of impella lp 2.5 and intra-aortic balloon pump in st-elevation myocardial infarction with refractory cardiogenic shock. |
| PubMedID- 24462137 | Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 19770739 | Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized iabp shock trial for attenuation of multiorgan dysfunction syndrome. |
| PubMedID- 25819870 | Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |
| PubMedID- 21285933 | Early revascularization is the cornerstone treatment of acute myocardial infarction complicated by cardiogenic shock. |
| PubMedID- 20089520 | Right ventricular dysfunction is an independent predictor for mortality in st-elevation myocardial infarction patients presenting with cardiogenic shock on admission. |
| PubMedID- 20732481 | Background: the mortality rate of patients experiencing acute myocardial infarction (ami) complicated by cardiogenic shock remains high. |
| PubMedID- 21226896 | Hypertensive crisis may develop in some patients resulting in cardiovascular shock with stroke, myocardial infarction, or multiple organ failure [5,6]. |
| PubMedID- 25136881 | Immediate multivessel percutaneous coronary intervention versus culprit lesion intervention in patients with acute myocardial infarction complicated by cardiogenic shock: results of the alkk-pci registry. |